Evidence map›Paper›PMID 30695021›Full record

ArticlePloS one2019

Abrogation of Stem Loop Binding Protein (Slbp) function leads to a failure of cells to transition from proliferation to differentiation, retinal coloboma and midline axon guidance deficits.

Katherine J Turner, Jacqueline Hoyle, Leonardo E Valdivia, Kara L Cerveny, Wendy Hart, Maryam Mangoli, Robert Geisler, Michele Rees, Corinne Houart, Richard J Poole and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Identification ofeLife · 2020
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Katherine J TurnerDepartment of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom.ORCID 0000-0002-3867-2684
Jacqueline HoyleDepartment of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom.
Leonardo E ValdiviaDepartment of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom.
Kara L CervenyDepartment of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom.
Wendy HartDepartment of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom.
Maryam MangoliDepartment of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom.ORCID 0000-0001-7364-6409
Robert GeislerKarlsruhe Institute of Technology (KIT) Institute of Toxicology and Genetics, Eggenstein-Leopoldshafen, Germany.ORCID 0000-0002-3909-8311
Michele ReesDepartment of Paediatrics and Child Health, University College London, London, United Kingdom.
Corinne HouartDepartment of Developmental Neurobiology and MRC Centre for Developmental Disorders, Kings College London, London, United Kingdom.
Richard J PooleDepartment of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom.ORCID 0000-0001-6414-2479
Stephen W WilsonDepartment of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom.ORCID 0000-0002-8557-5940
Gaia GestriDepartment of Cell and Developmental Biology, Division of Biosciences, University College London, London, United Kingdom.ORCID 0000-0001-8854-1546
University College London · GBKarlsruhe Institute of Technology · DEKing's College London · GBUniversidad Mayor · CL

Funding

Medical Research Council G0900994Medical Research Council MR/L003775/1Wellcome Trust 089227/Z09/ZWellcome Trust 095722/Z/11/ZWellcome Trust 104682/Z/14/ZWellcome Trust 207483/Z/17/Z
6 · The paper itself

Abstract

Through forward genetic screening for mutations affecting visual system development, we identified prominent coloboma and cell-autonomous retinal neuron differentiation, lamination and retinal axon projection defects in eisspalte (ele) mutant zebrafish. Additional axonal deficits were present, most notably at midline axon commissures. Genetic mapping and cloning of the ele mutation showed that the affected gene is slbp, which encodes a conserved RNA stem-loop binding protein involved in replication dependent histone mRNA metabolism. Cells throughout the central nervous system remained in the cell cycle in ele mutant embryos at stages when, and locations where, post-mitotic cells have differentiated in wild-type siblings. Indeed, RNAseq analysis showed down-regulation of many genes associated with neuronal differentiation. This was coincident with changes in the levels and spatial localisation of expression of various genes implicated, for instance, in axon guidance, that likely underlie specific ele phenotypes. These results suggest that many of the cell and tissue specific phenotypes in ele mutant embryos are secondary to altered expression of modules of developmental regulatory genes that characterise, or promote transitions in, cell state and require the correct function of Slbp-dependent histone and chromatin regulatory genes.

Indexed as

Animals, Genetically ModifiedCell DifferentiationCell ProliferationColobomaRetinal DiseasesZebrafishAnimalsAxon GuidanceHistonesRNA, MessengerZebrafish ProteinsHistonesRNA, MessengerZebrafish Proteins

Identifiers

PMID30695021
PMCPMC6350959
OpenAlexW2898942800

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.